Support The World's Smartest Network

Help the New York Academy of Sciences bring late-breaking scientific information about the COVID-19 pandemic to global audiences. Please make a tax-deductible gift today.

This site uses cookies.
Learn more.


This website uses cookies. Some of the cookies we use are essential for parts of the website to operate while others offer you a better browsing experience. You give us your permission to use cookies, by continuing to use our website after you have received the cookie notification. To find out more about cookies on this website and how to change your cookie settings, see our Privacy policy and Terms of Use.

We encourage you to learn more about cookies on our site in our Privacy policy and Terms of Use.

Ben Barres

Ben Barres, MD, PhD

September 13, 1954 – December 27, 2017

Dr. Barres was a neuroscientist at Stanford University; he served as Chair of Neurobiology from 2008-2016 and was the creator and director of the Masters of Science in Medicine Degree Program. He is credited with pioneering the study of neuron-glial interactions in the CNS. His lab focused on studying the basis of CNS neurodegenerative diseases, axon regeneration and remyelination failures, and the implication of astrocytes and microglia in health and disease. In 2011, Dr. Barres co-founded Annexon Biosciences Inc., with the hope of leveraging his lab’s findings in the development of new drugs for Alzheimer’s and other neurological diseases.

Beyond research, Dr. Barres was an ardent advocate for gender equality in science. He was the first openly transgender scientist elected to the National Academy of Science. Among his many distinctions, Dr. Barres was also elected a Fellow of the American Academy of Arts and Sciences, a member of the American Association for the Advancement of Science, and a member of the National Academy of Medicine.